Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Evolving symbiosis—venture capital and biotechnology

Nature Biotechnology volume 21, pages 983–984 (2003)Cite this article

A Corrigendum to this article was published on 01 April 2007

Beginnings

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Private funding of biotechnology ventures over the past 8 years.

Author information

Authors and Affiliations

  1. Ernst & Young, 1111 Summer Street, Stamford, 06905, Connecticut, USA

    Terry C Bradford

Authors
  1. Terry C Bradford
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bradford, T. Evolving symbiosis—venture capital and biotechnology. Nat Biotechnol 21, 983–984 (2003). https://doi.org/10.1038/nbt0903-983

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0903-983

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing